UFPT
NasdaqUFP Technologies, Inc.
Technology · Surgical & Medical Instruments & Apparatus
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$206.3M
2021
$353.8M
2022
$400.1M
2023
$504.4M
2024
$602.8M
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$602.8M
Net Income$68.3M
Gross Profit$170.4M
Oper Income$92.3M
EPS (dil)$8.75
Rev/sh$77.91
FCF/sh$10.63
Book/sh$54.79
Gross M28.3%
Oper M15.3%
Profit M11.3%
FCF M13.6%
ROE16.1%
ROA10.4%
ROIC13.9%
R&D/Rev1.4%
Rev Y/Y19.5%
Rev 3Y CAGR19.4%
EPS Y/Y15.4%
EPS 3Y CAGR17.1%
FCF 3Y CAGR85.7%
Payout—
Div/sh—
Shs Chg Y/Y+0.2%
Current Ratio2.68
Quick Ratio1.52
Debt/Eq0.35
Int Coverage9.4×
Net Debt$127.7M
Total Debt$148.0M
Cash & Eq$20.3M
Total Assets$655.1M
Oper CF$91.9M
Capex$9.7M
Free CF$82.2M
Buybacks$587,000
Equity$423.9M
Liabilities$231.2M
Shs Outstand0.01B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $206.3M | $353.8M | $400.1M | $504.4M | $602.8M |
| Gross Profit | $51.1M | $90.3M | $112.2M | $146.7M | $170.4M |
| Operating Income | $21.2M | $55.4M | $57.7M | $80.9M | $92.3M |
| Net Income | $15.9M | $41.8M | $44.9M | $59.0M | $68.3M |
| Diluted EPS | $2.09 | $5.45 | $5.83 | $7.58 | $8.75 |
| Operating Cash Flow | $14.3M | $17.7M | $41.3M | $66.6M | $91.9M |
| Free Cash Flow | $8.9M | $4.0M | $30.8M | $56.9M | — |
COMMUNITY · $UFPT0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.